News
Mesenchymal stem cell therapy lessens disability and brain lesions in MS patients, according to a review of published studies ...
People with MS visited doctors, were hospitalized, and used emergency care more than other people decades before their ...
Vibration therapy eases fatigue and improves motor and cognitive outcomes in MS, outperforming standard physical exercise ...
Columnist Leigh Anne Nelson rethinks her MS medication, discovering a risk and navigating crucial treatment decisions with ...
GFAP, or glial fibrillary acidic protein, supports star-shaped brain cells called astrocytes that help maintain nerve cell ...
Neural stem cell treatment was safe and significantly boosted myelin repair in spinal cord lesions in a mouse model of MS, ...
The rates of people MS advancing from RRMS to SPMS have decreased significantly in the past decades, according to a 30-year study in Italy.
Steve Bryson is a science writer for Multiple Sclerosis News Today with a PhD in biochemistry. He covers the latest news and information on a variety of multiple sclerosis topics.
Quantum Biopharma filed an innovation passport application in the U.K. to expedite the development and review of MS therapy ...
Columnist Ben Hofmeister reveals how MS heat sensitivity now hinders his ability to fully enjoy summer activities.
Most people with MS who are treated with formulations of botulinum toxin to manage spasticity report being satisfied, a study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results